Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells

Blood

Volumn 115, Issue 14, 2010, Pages 2810-2817

  Merluzzi, Sonia ^a   Frossi, Barbara ^a   Gri, Giorgia ^a   Parusso, Serena ^a   Tripodo, Claudio ^b   Pucillo, Carlo ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; IMMUNOGLOBULIN A; INTERLEUKIN 6; SYNDECAN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CELL EXPANSION; CELL PROLIFERATION; COCULTURE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SPLEEN CELL;

EID: 77950984998     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-10-250126     Document Type: Article

References (50)

1. Frossi B, De Carli M, Pucillo C. The mast cell: an antenna of the microenvironment that directs the immune response. J Leukoc Biol. 2004;75(4):579-585. (Pubitemid 38405648)
2. Galli SJ, Nakae S, Tsai M. Mast cells in the development of adaptive immune responses. Nat Immunol. 2005;6(2):135-142. (Pubitemid 40268194)
3. Metz M, Maurer M. Mast cells: key effector cells in immune responses. Trends Immunol. 2007;28(5):234-241. (Pubitemid 46654869)
4. Piconese S, Gri G, Tripodo C, et al. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17- cell differentiation. Blood. 2009;114(13):2639-2648.
5. Gri G, Piconese S, Frossi B, et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity. 2008;29(5):771-781.
6. Nakae S, Suto H, Iikura M, et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol. 2006;176(4):2238-2248. (Pubitemid 43201671)
7. Qiao H, Andrade MV, Lisboa FA, Morgan K, Beaven MA. FcepsilonR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood. 2006;107(2):610-618. (Pubitemid 43076385)
8. Stassen M, Hultner L, Schmitt E. Classical and alternative pathways of mast cell activation. Crit Rev Immunol. 2002;22(2):115-140. (Pubitemid 35244754)
9. Chen Y, Pappu BP, Zeng H, et al. B cell lymphoma 10 is essential for FcepsilonR-mediated degranulation and IL-6 production in mast cells. J Immunol. 2007;178(1):49-57. (Pubitemid 46033586)
10. Kashiwakura J, Yokoi H, Saito H, Okayama Y. T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lungcultured mast cells. J Immunol. 2004;173(8):5247-5257. (Pubitemid 39387808)
11. Galinsky DS, Nechushtan H. Mast cells and cancer: no longer just basic science. Crit Rev Oncol Hematol. 2008;68(2):115-130.
12. Hedström G, Berglund M, Molin D, et al. Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma. Br J Haematol. 2007;138(1):68-71. (Pubitemid 46889780)
13. Ho AW, Hatjiharissi E, Ciccarelli BT, et al. CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia. Blood. 2008;112(12):4683- 4689.
14. Horny HP, Sotlar K, Stellmacher F, Valent P, Grabbe J. An unusual case of systemic mastocytosis associated with chronic lymphocytic leukaemia (SM-CLL). J Clin Pathol. 2006;59(3):264-268. (Pubitemid 43344887)
15. Molin D, Edstrom A, Glimelius I, et al. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol. 2002;119(1):122-124. (Pubitemid 35176509)
16. Tournilhac O, Santos DD, Xu L, et al. Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling. Ann Oncol. 2006;17(8):1275-1282. (Pubitemid 44288218)
17. Huang B, Lei Z, Zhang GM, et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 2008;112(4):1269-1279.
18. Coussens LM, Raymond WW, Bergers G, et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 1999;13(11):1382-1397. (Pubitemid 29270244)
19. Nakayama T, Yao L, Tosato G. Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. J Clin Invest. 2004;114(9):1317-1325. (Pubitemid 40385303)
20. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med. 2007;13(10):1211-1218. (Pubitemid 47530639)
21. Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Nilsson G, Harvima IT. Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma. Cancer Immunol Immunother. 2007;56(9):1407-1415. (Pubitemid 47024710)
22. Eichenauer DA, Simhadri VL, von Strandmann EP, et al. ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro. Cancer Res. 2007;67(1):332-338.
23. Fischer M, Harvima IT, Carvalho RF, et al. Mast cell CD30 ligand is upregulated in cutaneous inflammation and mediates degranulationindependent chemokine secretion. J Clin Invest. 2006;116(10):2748-2756. (Pubitemid 44511638)
24. Tripodo C, Di Bernardo A, Ternullo MP, et al. CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis. Haematologica. 2009;94(1):127-130.
25. Merluzzi S, Moretti M, Altamura S, et al. CD40 stimulation induces Pax5/BSAP and EBF activation through a APE/Ref-1-dependent redox mechanism. J Biol Chem. 2004;279(3):1777-1786. (Pubitemid 38084445)
26. Frossi B, Rivera J, Hirsch E, Pucillo C. Selective activation of Fyn/PI3K and p38 MAPK regulates IL-4 production in BMMC under nontoxic stress condition. J Immunol. 2007;178(4):2549-2555. (Pubitemid 46233457)
27. Shaffer AL, Rosenwald A, Hurt EM, et al. Signatures of the immune response. Immunity. 2001;15(3):375-385.
28. Merluzzi S, Gri G, Gattei V, Pagano M, Pucillo C. APE/Ref-1 makes fine-tuning of CD40-induced B cell proliferation. Mol Immunol. 2008;45(14):3731-3739.
29. Barker J, Verfaillie CM. A novel in vitro model of early human adult B lymphopoiesis that allows proliferation of pro-B cells and differentiation to mature B lymphocytes. Leukemia. 2000;14(9):1614-1620.
30. Chng WJ, Schop RF, Price-Troska T, et al. Geneexpression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood. 2006;108(8):2755-2763.
31. Janz S. Genetic and environmental cofactors of Myc translocations in plasma cell tumor development in mice. J Natl Cancer Inst Monogr. 2008(39):37-40.
32. Lam LT, Wright G, Davis RE, et al. Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood. 2008;111(7):3701-3713.
33. Nishimoto N, Kishimoto T. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol. 2006;2(11):619-626.
34. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest. 1997;99(7):1492-1499. (Pubitemid 27163799)
35. Hasbold J, Corcoran LM, Tarlinton DM, Tangye SG, Hodgkin PD. Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation. Nat Immunol. 2004;5(1):55-63.
36. Kunimoto DY, Nordan RP, Strober W. IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. J Immunol. 1989;143(7):2230-2235.
37. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ. Immune regulation by CD40 and its ligand Gp39. Ann Rev Immunol. 1996;14:591-617.
38. Takatsu K. Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev. 1998;9(1):25-35.
39. Lebman DA, Edmiston JS. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect. 1999;1(15):1297-1304.
40. Lee JR, Koretzky GA. Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur J Immunol. 1998;28(12):4188-4197.
41. Chen X, Feng BS, Zheng PY, et al. Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine. Am J Pathol. 2008;173(6):1647-1656.
42. Shikina T, Hiroi T, Iwatani K, et al. IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut. J Immunol. 2004;172(10):6259-6264.
43. Satodate R, Schwarze EW, Lennert K. Tissue mast cell count in immunocytoma and chronic lymphocytic leukaemia [author's translation]. Virchows Arch A Pathol Anat Histol. 1977;373(4):303-309.
44. Fischer M, Juremalm M, Olsson N, et al. Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue. Int J Cancer. 2003;107(2):197-201.
45. Taskinen M, Karjalainen-Lindsberg ML, Leppa S. Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with Rituximab and CHOP. Blood. 2008;111(9):4664-4667.
46. Glimelius I, Edstrom A, Fischer M, et al. Angiogenesis and mast cells in Hodgkin lymphoma. Leukemia. 2005;19(12):2360-2362.
47. Collins M, Ling V, Carreno BM. The B7 family of immune-regulatory ligands. Genome Biol. 2005;6(6):223-230.
48. Lee BO, Moyron-Quiroz J, Rangel-Moreno J, et al. CD40, but not CD154, expression on B cells is necessary for optimal primary B cell responses. J Immunol. 2003;171(11):5707-5717. (Pubitemid 37467185)
49. Kim PH, Kagnoff MF. Transforming growth factor-beta 1 is a costimulator for IgA production. J Immunol. 1990;144(9):3411-3416. (Pubitemid 20146372)
50. Li E, Zhou P, Petrin Z, et al. Mast cell dependent control of Giardia lamblia infections in mice. Infect Immun. 2004;72(11):6641-6649. (Pubitemid 39425447)